转化生物医学

  • 国际标准期刊号: 2172-0479
  • 期刊 h 指数: 16
  • 期刊引用分数: 5.91
  • 期刊影响因子: 3.66
索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 期刊目录
  • 研究圣经
  • 全球影响因子 (GIF)
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 电子期刊图书馆
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Translational Biomedicine: The Future of Modern Internal Medicine

Sandeep Kumar Kar

From times immemorial the central dogma of life, i.e., DNA→RNA→Protein has been respected. This forms basic element of Translational Biomedicine. Interventions need to be directed at the three distinct steps at the DNA level (if feasible) or at the RNA level (through appropriate viral mediated vectors) or at the last step where the molecular medicine experts need to develop appropriate protein counterparts which will result in physiological effects by acting as agonist or antagonist at appropriate receptors. This forms the basis of translational biomedicine. Recently the Human Micro biome project has been Carisoprodol 350 mg tablet street value a great leap in this aspect.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证